Categories: EHRNews

Residex® AI acquires Kevala AI to enhance Senior Care operations, through AI Workforce Management.

DENVER and SEATTLE, Aug. 18, 2025 /PRNewswire/ — Residex.AI, a leading provider of Electronic Health Record (EHR) and clinical electronic Medication Administration Record (eMAR) for senior living communities, today announced the acquisition of Kevala, an AI-powered workforce management platform. The acquisition strengthens Residex’s position in the senior care technology market by adding staffing optimization to its clinical assessment, incident management and care planning platform, and comes at a time when senior care facilities face unprecedented challenges including staffing shortages, rising operational costs, and increasing regulatory requirements.

Residex’s platform serves as the foundation for senior care facilities, providing a comprehensive platform that manages resident health records, medication administration, care planning, assessments, and clinical documentation. The platform’s intelligent care modules automate clinical workflows, ensure regulatory compliance, and provide real-time insights into resident health trends. By integrating Kevala’s AI solution, Quin™, specializing in workforce optimization and predictive scheduling based on resident acuity levels and staff qualifications, the combined platform will ensure quality care delivery both clinically and operationally.

Chris Poelma, CEO of Residex.AI, said, “This acquisition represents a strategic milestone in our mission to transform senior care through technology. Kevala’s innovative approach to workforce management perfectly complements our clinical platform. While we’ve excelled at helping facilities document and plan care, Kevala ensures we have the optimal workforce management solution to deliver that care. Together, we’re creating the industry’s first truly integrated solution that manages both clinical operations and workforce optimization, empowering providers to deliver exceptional care while controlling costs.”

“We are thrilled to join forces with Residex to bring Quin™’s transformative AI capabilities to a broader community of senior care providers,” said Todd Owens, CEO and Co-Founder of Kevala. “This acquisition validates our vision of using AI to solve the industry’s most pressing operational challenge of ensuring topline workforce management. By combining Quin™’s workforce intelligence with Residex’s clinical expertise, we’re creating a powerful ecosystem that ultimately enhances the quality of life for residents.”

About Residex.AI

Residex.AI provides comprehensive AI enabled EHR and clinical eMAR platform designed specifically for senior living communities. The company’s platform helps facilities manage clinical documentation, care planning, medication administration, and regulatory compliance through intelligent automation and real-time insights.

About Kevala

Kevala offers AI-powered workforce management technology that optimizes staffing schedules, tracks credentials, and predicts staffing needs in senior care facilities through its flagship solution, Quin™.

View original content to download multimedia:https://www.prnewswire.com/news-releases/residex-ai-acquires-kevala-ai-to-enhance-senior-care-operations-through-ai-workforce-management-302531758.html

SOURCE Residex.ai

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

1 hour ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

4 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

4 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

4 hours ago